BRIEF-Supernus Pharmaceuticals Q1 Adjusted Operating Earnings USD 25.9 Million Vs. IBES Estimate USD 24.1 Million

Reuters
07 May
BRIEF-<a href="https://laohu8.com/S/SUPN">Supernus Pharmaceuticals</a> Q1 Adjusted Operating Earnings USD 25.9 Million Vs. IBES Estimate USD 24.1 Million

May 06 (Reuters) - Supernus Pharmaceuticals Q1 product sales USD 142 million.

  • Q1 operating earnings USD -10.256 million
  • Q1 adjusted revenue USD 126.8 million vs. IBES estimate USD 146.9 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10